Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Transplant International

• Publication date

  2001-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S001470100002PMID 11793034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group.

  1999cited by this paper
• A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.

  1999cited by this paper
• The Banff 97 working classification of renal allograft pathology.

  1999cited by this paper
• Racial disparities in renal transplant outcomes.

  1999cited by this paper
• Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.

  1999cited by this paper
• Low systemic exposure to tacrolimus correlates with acute rejection.

  1999cited by this paper
• Tacrolimus vs Neoral in renal and renal/pancreas transplantation

  1999cited by this paper
• Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients.

  1999cited by this paper
• Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials

  1999cited by this paper
• Quantitative assessment of the first acute rejection as a predictor of renal transplant outcome.

  1999cited by this paper
• The vanishing importance of age in renal transplantation.

  1999cited by this paper
• COMPARISON OF MICROEMULSION AND CONVENTIONAL FORMULATIONS OF CYCLOSPORINE A IN PREVENTING ACUTE REJECTION IN DE NOVO KIDNEY TRANSPLANT PATIENTS1

  1999cited by this paper
• The Benelux experience with the combination of tacrolimus and mycophenolate mofetil.

  1999cited by this paper
• Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.

  1999cited by this paper
• The side-effects of ciclosporine-A and tacrolimus.

  1998cited by this paper
• Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.

  1998cited by this paper
• The effect of delayed graft function and early graft rejection on renal transplant outcome.

  1998cited by this paper
• Impact of early cyclosporin average blood concentration on early kidney transplant failure

  1998cited by this paper
• Prospective randomised study comparing tacrolimus (Prograf) and cyclosporin (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases

  1998cited by this paper
• An exploratory analysis of prognostic factors for patient outcome during the first year following renal transplantation. European Tacrolimus Multicentre Renal Study Group.

  1998cited by this paper
• Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes

  1998cited by this paper
• Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.

  1998cited by this paper
• Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients.

  1998cited by this paper
• Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.

  1998cited by this paper
• Long-term steroid side effects in renal transplantation need a safe steroid withdrawal: a single-center experience.

  1998cited by this paper
• Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506

  1998cited by this paper
• Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine

  1998cited by this paper
• Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.

  1998cited by this paper
• Tacrolimus rescue therapy for renal allograft rejection--five-year experience.

  1997cited by this paper
• Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients

  1997cited by this paper
• A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.

  1997cited by this paper
• Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.

  1997cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection - A report of the European Tacrolimus Multicenter Renal Study Group

  1997cited by this paper
• Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.

  1997cited by this paper
• Immunosuppressive Therapy In High-risk Transplant Patients: Dose-dependent Efficacy Of Mycophenolate Mofetil In African-american Renal Allograft Recipients1

  1997cited by this paper
• A Comparison Of Tacrolimus (fk506) And Cyclosporine For Immunosuppression After Cadaveric Renal Transplantation1

  1997cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.

  1997cited by this paper
• A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.

  1996cited by this paper
• One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group.

  1996cited by this paper
• Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.

  1996cited by this paper
• Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients.

  1996cited by this paper
• A New Microemulsion Formulation of Cyclosporin

  1996cited by this paper
• Hyperlipidaemia in renal transplantation—risk factor for long‐term graft outcome

  1995cited by this paper
• Acute rejection and renal allograft outcome.

  1995cited by this paper
• A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.

  1995cited by this paper
• The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival.

  1995cited by this paper
• A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.

  1995cited by this paper
• FK 506 versus cyclosporin in the prevention of renal allograft rejection — European pilot study: six-week results

  1995cited by this paper
• Effects of membrane characteristics on cytokine production by mononuclear cells in regular haemodialysis patients.

  1995cited by this paper
• FK 506: long-term study in kidney transplantation. Japanese FK 506 Study Group.

  1995cited by this paper
• Chronic rejection in renal transplant recipients – Risk factors and correlates

  1994cited by this paper
• THE IMPACT OF ACUTE REJECTION EPISODES ON LONG‐TERM GRAFT FUNCTION AND OUTCOME IN 1347 PRIMARY RENAL TRANSPLANTS TREATED BY 3 CYCLOSPORINE REGIMENS

  1993cited by this paper
• Early versus late acute renal allograft rejection: impact on chronic rejection.

  1993cited by this paper
• EARLY VERSUS LATE ACUTE RENAL ALLOGRAFT REJECTION: IMPACT ON CHRONIC REJECTION

  1993cited by this paper
• Relationship between early vs late acute rejection and onset of chronic rejection in kidney transplantation.

  1993cited by this paper
• FK 506 in clinical kidney transplantation.

  1991cited by this paper
• Long-term results in cadaveric renal transplantation under cyclosporine therapy.

  1991cited by this paper
• Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine.

  1988cited by this paper
• Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial.

  1983cited by this paper
• A randomized clinical trial of cyclosporine in cadaveric renal transplantation.

  1983cited by this paper
• Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

  1979cited by this paper
• Report of the committee on the genetic constitution of autosomes other than chromosomes 1,2 and 6.

  1976cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant’s Recipients: A Systematic Review

  2021cites this paper
• Improving outcomes for donation after circulatory death kidney transplantation: Science of the times

  2020cites this paper
• Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta‐analysis

  2014cites this paper
• The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity?

  2014cites this paper
• Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy

  2013cites this paper
• Comparison of tacrolimus with a cyclosporine microemulsion for immunosuppressive therapy in kidney transplantation.

  2013cites this paper
• Effect of Immunosuppressive Agents on Long-Term Survival of Renal Transplant Recipients

  2012cites this paper
• Prediction modeling of kidney transplant outcome

  2010cites this paper
• Long‐term graft function with tacrolimus and cyclosporine in renal transplantation: Paired kidney analysis

  2009cites this paper
• Use of tacrolimus in Chinese renal transplant recipients

  2009cites this paper
• Factors Associated With Progression of Interstitial Fibrosis in Renal Transplant Patients Receiving Tacrolimus and Mycophenolate Mofetil

  2009cites this paper
• Blood Pressure in Renal Transplant Recipients: Are There Independent Predictors for Achieving Target Blood Pressure?

  2009cites this paper
• Kidney Transplantation Decreases the Level and Procoagulant Activity of Circulating Microparticles

  2009cites this paper
• Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients.

  2007cites this paper
• Screening for fracture risk is mandatory in renal transplant patients on even low-dose maintenance steroids

  2007cites this paper
• Relevance of Posttransplant Flow Cytometric T- and B-cell Crossmatches in Tacrolimus-Treated Renal Transplant Patients

  2006cites this paper
• Paired kidney analysis of tacrolimus and cyclosporine microemulsion‐based therapy in Chinese cadaveric renal transplant recipients

  2006cites this paper
• Role of maintenance immunosuppressive regimen in kidney transplant outcome.

  2006cites this paper
• Epidemiology of crystal arthropathy.

  2006cites this paper
• How to decrease cardiovascular mortality in renal transplant recipients.

  2006cites this paper
• Immunosuppressive drug-induced diabetes.

  2006cites this paper
• High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation.

  2006cites this paper
• Preservation of renal function and cardiovascular risk factors.

  2006cites this paper
• Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk

  2006cites this paper
• New-Onset Gout after Kidney Transplantation: Incidence, Risk Factors and Implications

  2005cites this paper
• Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus?

  2005cites this paper
• Pathogenesis of Gout

  2005cites this paper
• PHYSIOLOGY IN MEDICINE: A SERIES OF ARTICLES LINKING MEDICINE WITH SCIENCE

  2005cites this paper
• Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

  2005cites this paper
• Tacrolimus (FK506) versus cyclosporine microemulsion (neoral) as maintenance immunosuppression therapy in kidney transplant recipients.

  2005cites this paper
• Renal Graft Survival and Calcineurin Inhibitor

  2005cites this paper
• CONTRIBUTIONS FROM THE EUROPEAN RESPIRATORY MONOGRAPH SERIES "LUNG TRANSPLANTATION" Edited by R.D. Levy, M. Estenne, W. Weder, M.G. Cosio Number 3 in this Series Immunosuppressive therapy after human lung transplantation

  2004cites this paper
• Tacrolimus based immunosuppression.

  2004cites this paper
• New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta‐Analysis

  2004cites this paper
• Drug-related dyslipidemia after renal transplantation.

  2004cites this paper
• Gout: on the brink of novel therapeutic options for an ancient disease.

  2004cites this paper
• [Dyslipidaemia and its management after immunosuppressive treatment].

  2004cites this paper
• Mécanismes des hyperlipidémies dues aux immunosuppresseurs

  2004cites this paper
• Mécanismes des hyperlipidémies dues aux immunosuppresseurs Dyslipidaemia and its Management after Immunosuppressive Treatment

  2004cites this paper
• Cardiovascular risk profile in nondiabetic renal transplant patients: cyclosporine versus tacrolimus.

  2003cites this paper
• Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients.

  2003cites this paper
• Effects of tacrolimus on ischemia‐reperfusion injury

  2003cites this paper
• A comparison between cyclosporine and tacrolimus-based immunosuppression for renal allografts: renal function and blood pressure after 5 years.

  2003cites this paper
• Single-center experience with tacrolimus-based immunosuppressive regimens in renal transplantation.

  2003cites this paper
• Contributions from the European Respiratory Monograph Series "lung Transplantation" Edited Immunosuppressive Therapy after Human Lung Transplantation

  2003cites this paper
• Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus.

  2003cites this paper
• Tacrolimus (FK506) versus cyclosporin A microemulsion (Neoral) maintenance immunosuppression: effects on graft survival and function, infection, and metabolic profile following kidney transplantation (KT).

  2003cites this paper
• Long-term graft survival with neoral and tacrolimus: a paired kidney analysis.

  2003cites this paper
• Increase in tacrolimus trough levels after steroid withdrawal

  2003cites this paper
• Safety and efficacy of tacrolimus rescue therapy in 55 kidney transplant patients treated with cyclosporine.

  2003cites this paper
• Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study.

  2002cites this paper
• Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study

  2002cites this paper
• Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction.

  2002cites this paper
• Dialysis and Transplantation

  2001cites this paper